Skip to main content

Table 1 Signalment and renal biomarker data of ADPKD and control cats

From: Kidney and cystic volume imaging for disease presentation and progression in the cat autosomal dominant polycystic kidney disease large animal model

Cat ID

Agea (mo)

Weight (kg)

Sex

SDMA (0–14)

sCr (0.5–2.2)

BUN (19–35)

USG (1.035<)

GFR (2.5<)

Case 1

46.44

4.3

M

9

1.1

16

1.051

2.3

Case 2

97.08

3.9

F

15

1.6

24

1.028

2.78

Case 2b

~ 112

3.9

F

NA

2.4

36

1.015

NA

Case 2b

~ 116

2.7

F

NA

11.9

260

NA

NA

Case 3

19.44

3.6

F

12

1.2

24

1.055

3.95

Case 3b

~ 32

~ 3.6

F

14

1.3

24

1.046

NA

Case 4

33.72

3.4

F

9

1.2

22

1.06

2.6

Case 5

46.08

5.5

M

12

1.2

19

1.062

2.18

Case 6

47.04

4.2

M

9

0.9

13

1.06

3.12

Case 6b

~ 63

~ 4.2

M

8

0.7

18

1.062

 

Case 7

33.36

5.2

F

9

1

18

1.064

2.15

Case 8

22.92

6.0

M

8

0.9

14

1.06

2.83

Case 9

58.68

4.7

M

4

0.9

16

1.066

3.3

Case 10

15.12

4.1

F

8

0.9

21

1.08

3.28

Case 11

16.44

4.8

M

8

0.9

13

1.056

2.64

mean ± SD

39.67 ± 23.89

4.52 ± 0.81

6F:7M

9.36 ± 2.84

1.07 ± 0.22

18.18 ± 4.14

1.058 ± 0.013

2.83 ± 0.55

Control 1

15.12

3

M

4

0.9

17

1.063

2.66

Control 2

17.88

4.86

F

8

0.9

24

1.066

2.97

  1. aAge at time of imaging. M Male, F Female, SDMA Symmetric dimethylarginine (ug/dL), sCr serum creatinine (mg/dL), BUN Blood urea nitrogen (mg/dL), USG Urine specific gravity, GFR Glomerular filtration rate (ml/min/kg), NA Not available. bFollow-up values were not used to calculate means ± SD